According to reports from Business Standard, Hikal has successfully commenced commercial production of its personal care products at its new cGMP-compliant manufacturing facility located at Panoli, Gujarat. The facility has recently commenced commercial production and successfully manufactured its first production batches, with product samples being validated with customers. The company has received encouraging feedback from customers, resulting in a positive market pull for its product portfolio. As per the latest company announcement, this milestone represents a significant step in Hikal's strategic expansion into the global beauty and personal care industry.
As reported by Business Standard, this milestone marks Hikal's formal entry into commercial-scale supply for the global beauty and personal care industry. The company has repurposed an existing manufacturing asset at Panoli to serve the evolving needs of the global beauty and personal care industry, leveraging its decades of process chemistry and regulatory manufacturing experience to serve a new customer base. This development represents the latest step in the company's broader strategy of building new, high-value growth platforms alongside its established Pharmaceuticals, Crop Protection and growing Animal Healthcare business. The facility adds to Hikal's broader capability-building across its platform, including a recent cGMP pilot plant commissioning at its Pune Research & Technology campus to strengthen pharmaceutical process development capabilities.
Hikal's initial focus within Personal Care is on the Beauty & Personal Care segment, particularly the skin care category, where demand continues to grow globally. The company has built a strong portfolio of second-generation UV filters, offering enhanced performance and closer alignment with evolving consumer preferences and tightening regulatory requirements across key markets. These products are currently undergoing approvals by its global customers as part of the company's continued strategy of portfolio diversification beyond its core Pharma and Crop Protection segments. The company's initial focus within Personal Care is on the Beauty & Personal Care segment, particularly the skin care category, where demand continues to grow globally.
The announcement follows Hikal's recent EcoVadis Gold Medal rating for sustainability excellence, placing the company among the top 5% of more than 175,000 companies assessed globally. With an overall score of 84/100 and a 97th percentile ranking, the recognition reinforces Hikal's commitment to responsible manufacturing, ethical business practices, sustainable procurement and long-term value creation across its businesses. Established in 1988, Hikal operates five manufacturing facilities in India at Maharashtra (Taloja and Mahad), Gujarat (Panoli) and Bengaluru (Jigani) and maintains a world-class Research & Technology centre at Pune, with facilities certified by Global Regulatory Authorities.
